Industry Research Reports
Home > Reports > Service & Software > Global Pharmaceutical Safety Assessment Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pharmaceutical Safety Assessment Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 135 Pages
Report ld: 4873003
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Pharmaceutical Safety Assessment market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Clinical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Safety Assessment leading manufacturers including Eurofins, LabCorp, Fujifilm Wako, Charles River, SGS, Intertek Group, CTI, Frontage, Medicilon, Wuxi Biologics, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Safety Assessment market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Eurofins
- LabCorp
- Fujifilm Wako
- Charles River
- SGS
- Intertek Group
- CTI
- Frontage
- Medicilon
- Wuxi Biologics
- Pharmaron
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Biological Drugs
- Chemical Drugs
Segment by Application
- Clinical
- Non-clinical
CHAPTER OUTLINE
Chapter 1: Defines the Pharmaceutical Safety Assessment study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pharmaceutical Safety Assessment: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Safety Assessment Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biological Drugs
1.2.3 Chemical Drugs
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Safety Assessment Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Non-clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Safety Assessment Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Safety Assessment Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmaceutical Safety Assessment Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmaceutical Safety Assessment Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Biological Drugs Market Size by Players
3.3.2 Chemical Drugs Market Size by Players
3.4 Global Pharmaceutical Safety Assessment Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Safety Assessment Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Safety Assessment Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmaceutical Safety Assessment Market Size by Type (2020-2031)
6.4 North America Pharmaceutical Safety Assessment Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Safety Assessment Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmaceutical Safety Assessment Market Size by Type (2020-2031)
7.4 Europe Pharmaceutical Safety Assessment Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Safety Assessment Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Safety Assessment Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Safety Assessment Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmaceutical Safety Assessment Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmaceutical Safety Assessment Market Size by Type (2020-2031)
9.4 Central and South America Pharmaceutical Safety Assessment Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Safety Assessment Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Safety Assessment Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Safety Assessment Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Safety Assessment Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins
11.1.1 Eurofins Corporation Information
11.1.2 Eurofins Business Overview
11.1.3 Eurofins Pharmaceutical Safety Assessment Product Features and Attributes
11.1.4 Eurofins Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Pharmaceutical Safety Assessment Revenue by Product in 2024
11.1.6 Eurofins Pharmaceutical Safety Assessment Revenue by Application in 2024
11.1.7 Eurofins Pharmaceutical Safety Assessment Revenue by Geographic Area in 2024
11.1.8 Eurofins Pharmaceutical Safety Assessment SWOT Analysis
11.1.9 Eurofins Recent Developments
11.2 LabCorp
11.2.1 LabCorp Corporation Information
11.2.2 LabCorp Business Overview
11.2.3 LabCorp Pharmaceutical Safety Assessment Product Features and Attributes
11.2.4 LabCorp Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.2.5 LabCorp Pharmaceutical Safety Assessment Revenue by Product in 2024
11.2.6 LabCorp Pharmaceutical Safety Assessment Revenue by Application in 2024
11.2.7 LabCorp Pharmaceutical Safety Assessment Revenue by Geographic Area in 2024
11.2.8 LabCorp Pharmaceutical Safety Assessment SWOT Analysis
11.2.9 LabCorp Recent Developments
11.3 Fujifilm Wako
11.3.1 Fujifilm Wako Corporation Information
11.3.2 Fujifilm Wako Business Overview
11.3.3 Fujifilm Wako Pharmaceutical Safety Assessment Product Features and Attributes
11.3.4 Fujifilm Wako Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.3.5 Fujifilm Wako Pharmaceutical Safety Assessment Revenue by Product in 2024
11.3.6 Fujifilm Wako Pharmaceutical Safety Assessment Revenue by Application in 2024
11.3.7 Fujifilm Wako Pharmaceutical Safety Assessment Revenue by Geographic Area in 2024
11.3.8 Fujifilm Wako Pharmaceutical Safety Assessment SWOT Analysis
11.3.9 Fujifilm Wako Recent Developments
11.4 Charles River
11.4.1 Charles River Corporation Information
11.4.2 Charles River Business Overview
11.4.3 Charles River Pharmaceutical Safety Assessment Product Features and Attributes
11.4.4 Charles River Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.4.5 Charles River Pharmaceutical Safety Assessment Revenue by Product in 2024
11.4.6 Charles River Pharmaceutical Safety Assessment Revenue by Application in 2024
11.4.7 Charles River Pharmaceutical Safety Assessment Revenue by Geographic Area in 2024
11.4.8 Charles River Pharmaceutical Safety Assessment SWOT Analysis
11.4.9 Charles River Recent Developments
11.5 SGS
11.5.1 SGS Corporation Information
11.5.2 SGS Business Overview
11.5.3 SGS Pharmaceutical Safety Assessment Product Features and Attributes
11.5.4 SGS Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.5.5 SGS Pharmaceutical Safety Assessment Revenue by Product in 2024
11.5.6 SGS Pharmaceutical Safety Assessment Revenue by Application in 2024
11.5.7 SGS Pharmaceutical Safety Assessment Revenue by Geographic Area in 2024
11.5.8 SGS Pharmaceutical Safety Assessment SWOT Analysis
11.5.9 SGS Recent Developments
11.6 Intertek Group
11.6.1 Intertek Group Corporation Information
11.6.2 Intertek Group Business Overview
11.6.3 Intertek Group Pharmaceutical Safety Assessment Product Features and Attributes
11.6.4 Intertek Group Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.6.5 Intertek Group Recent Developments
11.7 CTI
11.7.1 CTI Corporation Information
11.7.2 CTI Business Overview
11.7.3 CTI Pharmaceutical Safety Assessment Product Features and Attributes
11.7.4 CTI Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.7.5 CTI Recent Developments
11.8 Frontage
11.8.1 Frontage Corporation Information
11.8.2 Frontage Business Overview
11.8.3 Frontage Pharmaceutical Safety Assessment Product Features and Attributes
11.8.4 Frontage Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.8.5 Frontage Recent Developments
11.9 Medicilon
11.9.1 Medicilon Corporation Information
11.9.2 Medicilon Business Overview
11.9.3 Medicilon Pharmaceutical Safety Assessment Product Features and Attributes
11.9.4 Medicilon Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.9.5 Medicilon Recent Developments
11.10 Wuxi Biologics
11.10.1 Wuxi Biologics Corporation Information
11.10.2 Wuxi Biologics Business Overview
11.10.3 Wuxi Biologics Pharmaceutical Safety Assessment Product Features and Attributes
11.10.4 Wuxi Biologics Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Pharmaron
11.11.1 Pharmaron Corporation Information
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Pharmaceutical Safety Assessment Product Features and Attributes
11.11.4 Pharmaron Pharmaceutical Safety Assessment Revenue and Gross Margin (2020-2025)
11.11.5 Pharmaron Recent Developments
12 Pharmaceutical Safety AssessmentIndustry Chain Analysis
12.1 Pharmaceutical Safety Assessment Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Safety Assessment Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Safety Assessment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharmaceutical Safety Assessment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharmaceutical Safety Assessment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharmaceutical Safety Assessment Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pharmaceutical Safety Assessment Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical Safety Assessment Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pharmaceutical Safety Assessment by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Safety Assessment as of 2024)
Table 11. Global Pharmaceutical Safety Assessment Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pharmaceutical Safety Assessment Companies Headquarters
Table 13. Global Pharmaceutical Safety Assessment Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pharmaceutical Safety Assessment Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pharmaceutical Safety Assessment Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pharmaceutical Safety Assessment Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pharmaceutical Safety Assessment Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pharmaceutical Safety Assessment High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pharmaceutical Safety Assessment Growth Accelerators and Market Barriers
Table 25. North America Pharmaceutical Safety Assessment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pharmaceutical Safety Assessment Growth Accelerators and Market Barriers
Table 27. Europe Pharmaceutical Safety Assessment Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pharmaceutical Safety Assessment Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pharmaceutical Safety Assessment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pharmaceutical Safety Assessment Investment Opportunities and Key Challenges
Table 31. Central and South America Pharmaceutical Safety Assessment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pharmaceutical Safety Assessment Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pharmaceutical Safety Assessment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Eurofins Corporation Information
Table 35. Eurofins Description and Major Businesses
Table 36. Eurofins Product Features and Attributes
Table 37. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Eurofins Revenue Proportion by Product in 2024
Table 39. Eurofins Revenue Proportion by Application in 2024
Table 40. Eurofins Revenue Proportion by Geographic Area in 2024
Table 41. Eurofins Pharmaceutical Safety Assessment SWOT Analysis
Table 42. Eurofins Recent Developments
Table 43. LabCorp Corporation Information
Table 44. LabCorp Description and Major Businesses
Table 45. LabCorp Product Features and Attributes
Table 46. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. LabCorp Revenue Proportion by Product in 2024
Table 48. LabCorp Revenue Proportion by Application in 2024
Table 49. LabCorp Revenue Proportion by Geographic Area in 2024
Table 50. LabCorp Pharmaceutical Safety Assessment SWOT Analysis
Table 51. LabCorp Recent Developments
Table 52. Fujifilm Wako Corporation Information
Table 53. Fujifilm Wako Description and Major Businesses
Table 54. Fujifilm Wako Product Features and Attributes
Table 55. Fujifilm Wako Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Fujifilm Wako Revenue Proportion by Product in 2024
Table 57. Fujifilm Wako Revenue Proportion by Application in 2024
Table 58. Fujifilm Wako Revenue Proportion by Geographic Area in 2024
Table 59. Fujifilm Wako Pharmaceutical Safety Assessment SWOT Analysis
Table 60. Fujifilm Wako Recent Developments
Table 61. Charles River Corporation Information
Table 62. Charles River Description and Major Businesses
Table 63. Charles River Product Features and Attributes
Table 64. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Charles River Revenue Proportion by Product in 2024
Table 66. Charles River Revenue Proportion by Application in 2024
Table 67. Charles River Revenue Proportion by Geographic Area in 2024
Table 68. Charles River Pharmaceutical Safety Assessment SWOT Analysis
Table 69. Charles River Recent Developments
Table 70. SGS Corporation Information
Table 71. SGS Description and Major Businesses
Table 72. SGS Product Features and Attributes
Table 73. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. SGS Revenue Proportion by Product in 2024
Table 75. SGS Revenue Proportion by Application in 2024
Table 76. SGS Revenue Proportion by Geographic Area in 2024
Table 77. SGS Pharmaceutical Safety Assessment SWOT Analysis
Table 78. SGS Recent Developments
Table 79. Intertek Group Corporation Information
Table 80. Intertek Group Description and Major Businesses
Table 81. Intertek Group Product Features and Attributes
Table 82. Intertek Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Intertek Group Recent Developments
Table 84. CTI Corporation Information
Table 85. CTI Description and Major Businesses
Table 86. CTI Product Features and Attributes
Table 87. CTI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. CTI Recent Developments
Table 89. Frontage Corporation Information
Table 90. Frontage Description and Major Businesses
Table 91. Frontage Product Features and Attributes
Table 92. Frontage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Frontage Recent Developments
Table 94. Medicilon Corporation Information
Table 95. Medicilon Description and Major Businesses
Table 96. Medicilon Product Features and Attributes
Table 97. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Medicilon Recent Developments
Table 99. Wuxi Biologics Corporation Information
Table 100. Wuxi Biologics Description and Major Businesses
Table 101. Wuxi Biologics Product Features and Attributes
Table 102. Wuxi Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Wuxi Biologics Recent Developments
Table 104. Pharmaron Corporation Information
Table 105. Pharmaron Description and Major Businesses
Table 106. Pharmaron Product Features and Attributes
Table 107. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Pharmaron Recent Developments
Table 109. Raw Materials Key Suppliers
Table 110. Distributors List
Table 111. Market Trends and Market Evolution
Table 112. Market Drivers and Opportunities
Table 113. Market Challenges, Risks, and Restraints
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Safety Assessment Product Picture
Figure 2. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Biological Drugs Product Picture
Figure 4. Chemical Drugs Product Picture
Figure 5. Global Pharmaceutical Safety Assessment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Clinical
Figure 7. Non-clinical
Figure 8. Pharmaceutical Safety Assessment Report Years Considered
Figure 9. Global Pharmaceutical Safety Assessment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 11. Global Pharmaceutical Safety Assessment Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Pharmaceutical Safety Assessment Revenue Market Share by Region (2020-2031)
Figure 13. Global Pharmaceutical Safety Assessment Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Biological Drugs Revenue Market Share by Player in 2024
Figure 16. Chemical Drugs Revenue Market Share by Player in 2024
Figure 17. Global Pharmaceutical Safety Assessment Revenue Market Share by Type (2020-2031)
Figure 18. Global Pharmaceutical Safety Assessment Revenue Market Share by Application (2020-2031)
Figure 19. North America Pharmaceutical Safety Assessment Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Pharmaceutical Safety Assessment Revenue (US$ Million) in 2024
Figure 21. North America Pharmaceutical Safety Assessment Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Pharmaceutical Safety Assessment Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Pharmaceutical Safety Assessment Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Pharmaceutical Safety Assessment Revenue (US$ Million) in 2024
Figure 28. Europe Pharmaceutical Safety Assessment Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Pharmaceutical Safety Assessment Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 31. France Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Pharmaceutical Safety Assessment Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Pharmaceutical Safety Assessment Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Pharmaceutical Safety Assessment Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Pharmaceutical Safety Assessment Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 43. India Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Pharmaceutical Safety Assessment Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Pharmaceutical Safety Assessment Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Pharmaceutical Safety Assessment Revenue (US$ Million) in 2024
Figure 51. Central and South America Pharmaceutical Safety Assessment Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Pharmaceutical Safety Assessment Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Pharmaceutical Safety Assessment Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Pharmaceutical Safety Assessment Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Pharmaceutical Safety Assessment Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Pharmaceutical Safety Assessment Revenue (US$ Million) in 2024
Figure 57. South America Pharmaceutical Safety Assessment Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Pharmaceutical Safety Assessment Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Pharmaceutical Safety Assessment Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Pharmaceutical Safety Assessment Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Pharmaceutical Safety Assessment Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Pharmaceutical Safety Assessment Revenue (2020-2025) & (US$ Million)
Figure 63. Pharmaceutical Safety Assessment Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharmaceutical Safety Assessment market?
The top companies in the global Pharmaceutical Safety Assessment market are Eurofins、LabCorp、Fujifilm Wako.
Related Reports
Global Pharmaceutical Safety Assessment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical Safety Assessment market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 135
USD 4900.00
(Single User License)
Global Pharmaceutical Safety Assessment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Safety Assessment market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 93
USD 4250.00
(Single User License)
Pharmaceutical Safety Assessment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Safety Assessment was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 102
USD 3950.00
(Single User License)
Global Pharmaceutical Safety Assessment Market Research Report 2026
The global Pharmaceutical Safety Assessment market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 111
USD 2900.00
(Single User License)
Global Pharmaceutical Safety Assessment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Safety Assessment market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 99
USD 4250.00
(Single User License)
Pharmaceutical Safety Assessment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Safety Assessment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 116
USD 3950.00
(Single User License)
Global Pharmaceutical Safety Assessment Market Research Report 2025
The global market for Pharmaceutical Safety Assessment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 86
USD 2900.00
(Single User License)
Global Pharmaceutical Safety Assessment Market Research Report 2024
The global Pharmaceutical Safety Assessment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-07-10
Pages: 86
USD 2900.00
(Single User License)
Global and United States Pharmaceutical Safety Assessment Market Report & Forecast 2024-2030
The global Pharmaceutical Safety Assessment revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-10
Pages: 107
USD 4350.00
(Single User License)
Global Pharmaceutical Safety Assessment Market Insights, Forecast to 2030
The global Pharmaceutical Safety Assessment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-07-10
Pages: 138
USD 4900.00
(Single User License)
Global Pharmaceutical Safety Assessment Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical Safety Assessment market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 135
USD 4900.00 (Single User License)Global Pharmaceutical Safety Assessment Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Safety Assessment market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 93
USD 4250.00 (Single User License)Pharmaceutical Safety Assessment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Safety Assessment was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 102
USD 3950.00 (Single User License)Global Pharmaceutical Safety Assessment Market Research Report 2026
The global Pharmaceutical Safety Assessment market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 111
USD 2900.00 (Single User License)Global Pharmaceutical Safety Assessment Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Safety Assessment market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 99
USD 4250.00 (Single User License)Pharmaceutical Safety Assessment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmaceutical Safety Assessment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 116
USD 3950.00 (Single User License)Global Pharmaceutical Safety Assessment Market Research Report 2025
The global market for Pharmaceutical Safety Assessment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 86
USD 2900.00 (Single User License)Global Pharmaceutical Safety Assessment Market Research Report 2024
The global Pharmaceutical Safety Assessment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-07-10
Pages: 86
USD 2900.00 (Single User License)Global and United States Pharmaceutical Safety Assessment Market Report & Forecast 2024-2030
The global Pharmaceutical Safety Assessment revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-10
Pages: 107
USD 4350.00 (Single User License)Global Pharmaceutical Safety Assessment Market Insights, Forecast to 2030
The global Pharmaceutical Safety Assessment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-07-10
Pages: 138
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now